Clinical Trial Update: Optimizing the Therapeutic Dose of Apatinib Mesylate Tablets in Patients With Lung Cancer by Dose Titration：A Real World Exploratory Study [NA]

View source ↗

Summary

This real-world exploratory study investigates dose titration of apatinib mesylate tablets to optimize therapy in patients with non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Apatinib Mesylate Tablets (Apatinib)

Snippet

Sponsor: Beijing Chest Hospital | Conditions: NSCLC Stage IV, NSCLC Stage IIIB | NA | Status: UNKNOWN